We are building a strong, well-run business, structured to deliver sustainable results over the long term.
Along with biotechnology leadership, the ARIAD team is focused on its commitment
to deliver long-term value to investors through solid business execution. That means
maintaining disciplined cost control, thoughtful capital deployment and the highest
standards of corporate governance.
Webcast - Replay Q3 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call 11/05/14 at 8:30 a.m. ET
Q3 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call Wednesday, November 5, 2014 8:30 a.m. ET